Home/Filings/4/0001104659-22-011048
4//SEC Filing

Granfield Christine 4

Accession 0001104659-22-011048

CIK 0001509745other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 9:46 PM ET

Size

5.8 KB

Accession

0001104659-22-011048

Insider Transaction Report

Form 4
Period: 2022-01-31
Granfield Christine
VP, Head of Reg Affairs/Qual
Transactions
  • Award

    Restricted Stock Units

    2022-01-31+225,000225,000 total
    Exercise: $0.00Common Stock (225,000 underlying)
Footnotes (2)
  • [F1]The Restricted Stock Units were awarded pursuant to Leap's 2016 Equity Incentive Plan for no consideration. Restricted Stock Units will be settled in common stock.
  • [F2]The Restricted Stock Units will cliff vest and be settled after three years of continuous service or upon a change of control of Leap, whichever is earlier.

Issuer

LEAP THERAPEUTICS, INC.

CIK 0001509745

Entity typeother

Related Parties

1
  • filerCIK 0001822190

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 9:46 PM ET
Size
5.8 KB